A detailed history of True Wealth Design, LLC transactions in Argenx Se stock. As of the latest transaction made, True Wealth Design, LLC holds 2 shares of ARGX stock, worth $1,259. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 1 100.0%
Holding current value
$1,259
Previous $431,000 151.74%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$434.22 - $551.9 $434 - $551
1 Added 100.0%
2 $1.09 Million
Q2 2024

Aug 14, 2024

SELL
$356.01 - $451.55 $356 - $451
-1 Reduced 50.0%
1 $431,000
Q1 2024

May 14, 2024

BUY
$356.95 - $413.29 $356 - $413
1 Added 100.0%
2 $788,000
Q4 2022

Feb 15, 2023

BUY
$342.17 - $402.31 $342 - $402
1 New
1 $379,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.9B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.